| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |